Singh G, Thompson E B, Gulati A
Department of Pharmacodynamics (m/c 865), University of Illinois at Chicago 60612.
Pharmacology. 1994 Sep;49(3):184-91. doi: 10.1159/000139233.
Earlier studies have shown that plasma concentrations of endothelin 1 (ET-1) and the receptors for ET are altered during hyperthyroidism, while they are not affected during hypothyroidism. The present study was undertaken to determine the changes in concentration of endogenous ET-1 in various tissues of hyper- and hypothyroid rats. Hyperthyroidism was induced by daily administration of thyroxine (T4, 0.1 mg/kg, i.p.) for 8 weeks, while hypothyroidism was induced by daily administration of methimazole (10 mg/kg, i.p.) for 8 weeks. The concentration of endogenous ET-1 was determined in the brain regions (hypothalamus, corpus striatum, pituitary, hippocampus and spinal cord), heart, adrenals, kidneys and thoracic aorta using a radioimmunoassay procedure. Blood pressure and heart rate were significantly increased in hyperthyroid rats, while they were not affected in hypothyroid rats when compared with control (euthyroid) rats. Serum T4 and T3 levels were significantly increased in hyperthyroid rats, while they were significantly decreased in hypothyroid rats when compared with euthyroid rats. The concentrations of ET-1 in the hypothalamus, corpus striatum, hippocampus and spinal cord were not altered in hyper- or hypothyroid rats when compared with euthyroid rats. However, the pituitary showed a significant (p < 0.001) increase (104%) in ET-1 concentration in hyperthyroid rats when compared with euthyroid ones, while hypothyroid rats did not show any significant change in ET-1 concentration in the pituitary. In peripheral tissues ET-1 concentrations were not altered in the heart and adrenals of hyper- and hypothyroid rats when compared with euthyroid rats.(ABSTRACT TRUNCATED AT 250 WORDS)
早期研究表明,甲状腺功能亢进时血浆内皮素1(ET-1)及其受体浓度会发生改变,而甲状腺功能减退时则不受影响。本研究旨在确定甲状腺功能亢进和减退大鼠各组织中内源性ET-1浓度的变化。通过每日腹腔注射甲状腺素(T4,0.1mg/kg)8周诱导甲状腺功能亢进,通过每日腹腔注射甲巯咪唑(10mg/kg)8周诱导甲状腺功能减退。采用放射免疫分析法测定脑区(下丘脑、纹状体、垂体、海马和脊髓)、心脏、肾上腺、肾脏和胸主动脉中内源性ET-1的浓度。与对照(甲状腺功能正常)大鼠相比,甲状腺功能亢进大鼠的血压和心率显著升高,而甲状腺功能减退大鼠则不受影响。与甲状腺功能正常大鼠相比,甲状腺功能亢进大鼠血清T4和T3水平显著升高,而甲状腺功能减退大鼠则显著降低。与甲状腺功能正常大鼠相比,甲状腺功能亢进或减退大鼠下丘脑、纹状体、海马和脊髓中ET-1的浓度未发生改变。然而,与甲状腺功能正常大鼠相比,甲状腺功能亢进大鼠垂体中ET-1浓度显著升高(104%,p<0.001),而甲状腺功能减退大鼠垂体中ET-1浓度未显示任何显著变化。与甲状腺功能正常大鼠相比,甲状腺功能亢进和减退大鼠心脏和肾上腺外周组织中ET-1浓度未发生改变。(摘要截断于250字)